Produkty 59580-81-3

CAS 59580-81-3 występuje w naszej ofercie pod nazwami: (3b,4a,5a)-3,4-Dihydroxyandrostan-17-one, >95% (HPLC), (3β,4α,5α)-3,4-Dihydroxyandrostan-17-one, >95% (HPLC). Oferty producentów: TRC. Dostępne opakowania: 10mg, 1mg, 5mg.

(3b,4a,5a)-3,4-Dihydroxyandrostan-17-one, >95% (HPLC)
TRC
  • opakowanie: 10mg, 5mg
  • Warianty: 2
Zobacz produkt
(3β,4α,5α)-3,4-Dihydroxyandrostan-17-one, >95% (HPLC)
TRC
  • opakowanie: 1mg
  • Warianty: 1
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one (CAS 59580-81-3) to związek chemiczny o wzorze sumarycznym C19H30O3 i masie molowej 306.4 g/mol. Nazwa systematyczna IUPAC: (3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one. InChIKey: RFMKWBMPDNCUNR-ATMNEXLDSA-N.

Dane identyfikacyjne
Wzór sumarycznyC19H30O3
Masa molowa306.4 g/mol
Nazwa IUPAC(3S,4S,5R,8R,9S,10R,13S,14S)-3,4-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
InChIKeyRFMKWBMPDNCUNR-ATMNEXLDSA-N
SMILESC[C@]12CC[C@@H]([C@H]([C@@H]1CC[C@@H]3[C@@H]2CC[C@]4([C@H]3CCC4=O)C)O)O

Dane obliczone przez PubChem (NCBI)

Synonimy: (3b,4a,5a)-3,4-Dihydroxyandrostan-17-one, (3|A,4|A,5|A)-3,4-Dihydroxyandrostan-17-one
Izomery (ten sam wzór sumaryczny)
dodecyl 2-hydroxybenzoate C19H30O3
dodecyl 4-hydroxybenzoate C19H30O3
ethyl 3-(3,5-ditert-butyl-4-hydroxyphenyl)propanoate C19H30O3
(3R,5S,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(1S,3aS,3bR,5aR,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(4R,6R)-6-[2-[(1S,2S,4aR,6R,8aS)-2,6-dimethyl-1,2,4a,5,6,7,8,8a-octahydronaphthalen-1-yl]ethyl]-4-hydroxyoxan-2-one C19H30O3
(1S,3aS,3bR,5aS,9aR,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,8,9,9b,10,11-dodecahydroindeno[5,4-f]chromen-7-one C19H30O3
(1S,3aS,3bR,5aS,9aS,9bS,11aS)-1-hydroxy-1,9a,11a-trimethyl-2,3,3a,3b,4,5,5a,6,9,9b,10,11-dodecahydroindeno[4,5-h]isochromen-7-one C19H30O3
(4aS,4bR,6aR,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3
(3R,5R,8R,9S,10S,13S,14S,16R)-3,16-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(3R,5R,8S,9S,10S,11S,13S,14S)-3,11-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one C19H30O3
(4aS,4bR,6aS,8S,10aS,10bS,12aS)-8-hydroxy-10a,12a-dimethyl-3,4,4a,4b,5,6,6a,7,8,9,10,10b,11,12-tetradecahydronaphtho[2,1-f]chromen-2-one C19H30O3